美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
69844-064-01	69844-064	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	extended-release	TABLET	ORAL	20190128	N/A	ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	150 mg/1	30 TABLET in 1 BOTTLE (69844-064-01)
69844-064-02	69844-064	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	extended-release	TABLET	ORAL	20190128	N/A	ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	150 mg/1	90 TABLET in 1 BOTTLE (69844-064-02)
69844-064-03	69844-064	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	extended-release	TABLET	ORAL	20190128	N/A	ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	150 mg/1	1000 TABLET in 1 BOTTLE (69844-064-03)
69844-064-04	69844-064	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	extended-release	TABLET	ORAL	20190128	N/A	ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	150 mg/1	500 TABLET in 1 BOTTLE (69844-064-04)
69844-065-01	69844-065	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	extended-release	TABLET	ORAL	20190128	N/A	ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	300 mg/1	30 TABLET in 1 BOTTLE (69844-065-01)
69844-065-02	69844-065	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	extended-release	TABLET	ORAL	20190128	N/A	ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	300 mg/1	90 TABLET in 1 BOTTLE (69844-065-02)
69844-065-03	69844-065	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	extended-release	TABLET	ORAL	20190128	N/A	ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	300 mg/1	1000 TABLET in 1 BOTTLE (69844-065-03)
69844-065-04	69844-065	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	extended-release	TABLET	ORAL	20190128	N/A	ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	300 mg/1	500 TABLET in 1 BOTTLE (69844-065-04)
68788-8589-1	68788-8589	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240220	N/A	ANDA	ANDA211020	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-1)
68788-8589-3	68788-8589	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240220	N/A	ANDA	ANDA211020	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-3)
68788-8589-6	68788-8589	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240220	N/A	ANDA	ANDA211020	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-6)
68788-8589-8	68788-8589	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240220	N/A	ANDA	ANDA211020	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-8)
68788-8589-9	68788-8589	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240220	N/A	ANDA	ANDA211020	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-9)
16571-862-03	16571-862	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220801	N/A	ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-03)
16571-862-09	16571-862	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220801	N/A	ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-09)
16571-862-10	16571-862	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220801	N/A	ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-10)
16571-862-12	16571-862	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240603	N/A	ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	120 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-12)
16571-862-50	16571-862	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220801	N/A	ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-50)
16571-863-03	16571-863	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220801	N/A	ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-03)
16571-863-09	16571-863	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220801	N/A	ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-863-09)